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Background-—Psychosocial risk for cardiovascular disease (CVD) may be especially deleterious in persons with low socioeconomic
status. Most work has focused on psychosocial factors individually, but emerging research suggests that the confluence of
psychosocial risk may be particularly harmful. Using data from the Reasons for Geographical and Racial Differences in Stroke
(REGARDS) study, we examined associations among depressive symptoms and stress, alone and in combination, and incident CVD
and all-cause mortality as a function of socioeconomic status.
Methods and Results-—At baseline, 22 658 participants without a history of CVD (58.8% female, 41.7% black, mean age
63.99.3 years) reported on depressive symptoms, stress, annual household income, and education. Participants were classified
into 1 of 3 psychosocial risk groups at baseline: (1) neither depressive symptoms nor stress, (2) either depressive symptoms or
stress, or (3) both depressive symptoms and stress. Cox proportional hazards models were used to predict physician-adjudicated
incident total CVD events (nonfatal myocardial infarction, nonfatal stroke, and cardiovascular death) and all-cause mortality over a
median of 7.0 years (interquartile range 5.4–8.3 years) of follow-up. In fully adjusted models, participants with both depressive
symptoms and stress had the greatest elevation in risk of developing total CVD (hazard ratio 1.48, 95% CI 1.21–1.81) and all-cause
mortality (hazard ratio 1.33, 95% CI 1.13–1.56) but only for those with low income (<$35 000) and not high (≥$35 000) income.
This pattern of results was not observed in models stratified by education.
Conclusions-—Findings suggest that screening for a combination of elevated depressive symptoms and stress in low-income
persons may help identify those at increased risk of incident CVD and mortality. ( J Am Heart Assoc. 2016;5: e003930
doi: 10.1161/JAHA.116.003930)
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I n the United States, >85 million adults—>1 in 3—have atleast 1 type of cardiovascular disease (CVD), including
hypertension, coronary heart disease (CHD), and stroke.1
Furthermore, CVD remains the leading cause of death in the
United States and accounts for 1 death every 40 seconds.1
Despite advances in detection, prevention, and intervention,
continued efforts are needed to improve cardiovascular
health.
Emphasis has been placed on targeting health factors (eg,
cholesterol, blood pressure) and health behaviors (eg, physical
activity, diet) at both the individual and population levels to
reduce the burden of cardiovascular morbidity and mortality.2
Substantial evidence, however, has demonstrated that psy-
chosocial factors also contribute to the development of CVD.3
In particular, depression4–6 and perceived psychosocial
stress7–9 have been linked to increased CVD risk, and some
From the Center for Behavioral Cardiovascular Health, Columbia University Medical Center, New York, NY (J.A.S., K.W.D., D.E.); Department of Epidemiology, Harvard
T.H. Chan School of Public Health, Boston, MA (J.A.S.); Departments of Medicine (Y.K., N.R., M.W.L.) and Surgery (J.R.), School of Medicine and Department of
Epidemiology, School of Public Health (P.M.), University of Alabama at Birmingham, AL; Department of Medicine, Weill Cornell Medical College, New York, NY (M.M.S.).
Accompanying Tables S1 through S3 are available at http://jaha.ahajournals.org/content/5/10/e003930/DC1/embed/inline-supplementary-material-1.pdf
Correspondence to: Jennifer A. Sumner, PhD, Center for Behavioral Cardiovascular Health, Columbia University Medical Center, 622 W. 168th St, PH9-315, New
York, NY 10032. E-mail: js4456@cumc.columbia.edu
Received May 17, 2016; accepted September 14, 2016.
ª 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative
Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is
not used for commercial purposes.
DOI: 10.1161/JAHA.116.003930 Journal of the American Heart Association 1
ORIGINAL RESEARCH








research has demonstrated that the confluence of these 2
factors may be particularly deleterious for cardiovascular
health.10–12 This latter finding is consistent with a recently
proposed psychosocial “perfect storm” model13 of CVD risk
that suggests an underlying vulnerability (eg, depression) is
associated with greater risk of cardiac events and mortality,
particularly in the presence of perceived stress. Although
examinations of the association between depressive symp-
toms or stress and CVD are increasingly common,4,6–9,14–19
fewer studies have examined the combined effects of
depressive symptoms and stress.10,11 The perfect storm
model emphasizes the importance of considering the conver-
gence of a variety of factors that contribute to CVD risk rather
than focusing on 1 risk factor in isolation. It provides a useful
framework for studying the effects of depressive symptoms
and perceived stress alone and in combination, ultimately
elucidating the vulnerability and trigger mechanisms through
which depression and/or stress prompt CVD events.
The importance of social determinants of CVD risk has also
been increasingly appreciated.3 Socioeconomic status (SES)
has been emphasized as a key social factor with relevance to
differential CVD risk, with low income and limited educational
attainment exhibiting robust links to poor cardiovascular
outcomes.3 Furthermore, researchers have postulated that
persons with low SES may be particularly vulnerable to the
effects of psychosocial risk factors for poor physical health,
suggesting that such persons may have fewer economic,
social, and psychological resources for dealing with chal-
lenges compared with those with higher SES.20–22
Growing evidence indicates that psychosocial factors have
important physical health implications for persons with low
SES in particular. In the Health Survey for England cohort
study, participants with both high general psychological
distress and low SES were at the greatest risk of mortality
from CHD and stroke23 and of all-cause mortality.21 In
addition, in the Reasons for Geographic and Racial Differ-
ences in Stroke (REGARDS) study, elevated stress24 and
depressive symptoms25 were each separately associated with
increased risk of incident CVD events and death only for those
with annual household income <$35 000 and not with higher
income. Other findings from the REGARDS study suggested
that the joint influence of psychosocial risk factors on the
occurrence of CVD events and/or mortality may be more
pronounced for certain subgroups. Paralleling prior REGARDS
findings with respect to risk of CHD recurrence,10 Cummings
et al12 found that the combination of elevated stress and
depressive symptoms was most deleterious for risk of
cardiovascular death and that this was true for persons with,
but not without, diabetes mellitus. It is noteworthy that
persons with diabetes mellitus disproportionately live in
poverty.26 As population health management increasingly
becomes integrated into health care reform, better
understanding is needed of which subgroups should be
targeted for which types of interventions. These results
suggest that among persons with low SES, psychosocial
factors may be particularly important contributors to
increased rates of CVD events and mortality.
Using data from the REGARDS national longitudinal cohort
study, we examined the association among depressive
symptoms and perceived stress, alone and in combination,
and risk of incident CVD and all-cause mortality stratified as a
function of SES. Given prior findings in the REGARDS study
suggesting that individual psychosocial factors are particularly
associated with CVD risk in those with low versus high
income,24,25 we examined annual household income as our
primary SES indicator. Education was examined in a supple-
mental analysis. We hypothesized that the joint presence of
elevated depressive symptoms and perceived stress would be
associated with the greatest increase in risk of incident CVD
events and all-cause mortality in persons with low, but not
high, SES.
Methods
Study Design and Cohort Description
The REGARDS study is a prospective longitudinal observa-
tional cohort study of stroke risk in black and white adults
aged ≥45 years.27 The overarching aims of the investigation
are to better understand the causes of elevated stroke
morbidity and mortality observed in the southeastern United
States (the stroke “belt” and “buckle”) relative to the rest of
the nation and among black participants relative to white
participants. Between January 2003 and October 2007,
30 239 adults were recruited from the community in the
continental United States (42% black, 55% female, 55% from
the stroke belt) using a targeted recruitment strategy for
specific age, race, and geographic strata. The current study
used data from REGARDS-MI, an ancillary study that adjudi-
cated all heart-related events and causes of death and
incorporated them into the larger REGARDS data set.28
At baseline, participants were administered a computer-
assisted telephone interview assessing demographics,
medical history, functional status, health behaviors, and
psychosocial factors. In addition, participants completed an
in-home physical examination 3 to 4 weeks after the
telephone interview. At these examinations, trained health
care professionals used standardized quality-controlled pro-
tocols to collect anthropometric data (height and weight,
waist circumference), blood pressure, ECGs, blood and urine
samples, and medication use by pill bottle review. Participants
provided written informed consent during the in-home
examination. This study was approved by the Institutional
Review Board for Human Subjects at the University of
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Alabama at Birmingham and by all other participating
institutions. ECGs were analyzed by trained cardiologists at
Wake Forest University. Blood and urine samples were
analyzed at the University of Vermont. Every 6 months,
participants were contacted by telephone to query new-onset
CVD events, hospitalizations, and mortality, followed by
retrieval of medical records that formed the basis of
adjudication of end points. Proxies for deceased participants
were queried on 1 occasion to gather parallel information for
the deceased participant.
Psychosocial Measures
At baseline, participants completed measures of depressive
symptoms and perceived stress. Depressive symptoms were
assessed with the 4-item Center for Epidemiologic Studies
Depression (CES-D) questionnaire,29 a previously validated
version of the CES-D30 that has been found to correlate highly
with the original 20-item questionnaire (r=0.87) and to have
sensitivity of 79.2% and specificity of 81.2% compared with
the original version.29 Participants indicated the extent to
which they experienced each of 4 depressive symptoms (felt
depressed, felt lonely, had crying spells, felt sad) in the past
week on a scale from 1 (<1 day) to 4 (5–7 days). Responses
to the 4 items were summed (Cronbach a=0.80). Consistent
with previous research,10,12,18,25 we classified participants as
having elevated depressive symptoms if they had a CES-D
score ≥4, a validated cut point suggestive of clinically
significant levels of depressive symptoms.29
Perceived stress was measured with a 4-item version of
the Perceived Stress Scale (PSS),31 a well-validated instru-
ment for assessing perceptions of personal stress. The 4-item
version has been found to have adequate psychometric
properties and good predictive validity.32 Items measure the
degree to which participants view their lives as unpredictable,
uncontrollable, overloaded, or unable to be handled;
responses were summed to create a total score (Cronbach
a=0.72). There is no established cut point for high stress on
the PSS. In the current investigation, participants in the upper
tertile of total PSS score (≥5) were classified as having
elevated levels of perceived stress.
SES Indicators
At the baseline interview, participants reported their annual
household income. Consistent with previous research in the
REGARDS study,24,25 we categorized participants as low
income (<$35 000/year) or high income (≥$35 000/year),
given that this level of income was found tomodify associations
between perceived stress and CHD in a spline analysis.24 In
addition, participants reported their highest grade or year of
school completed. As in other REGARDS research,33 we
classified participants’ educational level as low (some high
school or less) or high (high school graduate or more).
Cardiovascular and Death Outcomes
For the current study, the primary outcome of interest was a
composite total CVD outcome comprising acute CHD,
nonfatal stroke, and cardiovascular death (CHD death, stroke
death, heart failure death, sudden cardiac death, other
cardiovascular-related death). Secondary analyses examined
acute CHD and cardiovascular death separately. We also
examined all-cause mortality as an outcome. At each
6-month follow-up assessment, trained interviewers adminis-
tered a standardized questionnaire assessing whether par-
ticipants had been hospitalized for stroke or CHD since the
last follow-up. If hospitalizations were reported, the date and
time of each event was recorded and medical records were
retrieved.
Acute CHD events comprised nonfatal myocardial infarc-
tion and CHD death events. Medical records were reviewed by
a physician-led team, and events were adjudicated following
established guidelines.34,35 Specifically, medical records were
examined for signs or symptoms of ischemia, a rising and/or
falling pattern in cardiac troponin or creatinine phosphoki-
nase-MB over ≥6 hours with a peak value greater than or
equal to twice the upper limit of normal (diagnostic cardiac
enzymes), and ECG changes consistent with ischemia or
myocardial infarction. Review was guided by the Minnesota
code, and events were classified as evolving diagnostic,
positive, nonspecific, or not consistent with ischemia.36,37
Each stroke event was adjudicated by medical record
review conducted by a neurologist-led team. World Health
Organization criteria38 were used to define stroke events,
although the study also included (1) events with symptoms
lasting <24 hours with neuroimaging consistent with acute
ischemia or hemorrhage and (2) cases with incomplete
information for World Health Organization or clinical classi-
fication but for which adjudicators agreed that the event was
likely a stroke or stroke-related death.
Deaths were detected through next-of-kin report, online
repositories (eg, Social Security Death Index), or the National
Death Index. Proxies or next of kin were interviewed to obtain
information about the circumstances of the death. Proxy
interviews, medical history, medical records in the final year
of life, death certificates, and autopsy reports were gathered
and reviewed by physician-led adjudicators to determine
whether the death was caused by CVD.34,35
Covariates
Data on sociodemographics, physiological and medical CVD
risk factors, and health behaviors were included in models as
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potential confounders. The following sociodemographic mea-
sures were assessed at baseline: race (black, white), age, sex,
number of persons (adults and children) living in the
household, and geographic region of residence (stroke belt,
stroke buckle, non–stroke belt or buckle). Several physiolog-
ical CVD risk factors were also measured from data collected
during the at-home examination: waist circumference (in cm),
systolic blood pressure (in mm Hg), total cholesterol (in mg/
dL), high-density lipoprotein (in mg/dL), estimated glomerular
filtration rate, high-sensitivity C-reactive protein (in mg/L),
and albumin-to-creatinine ratio (in mg/g). Antihypertensive
medication use and statin use were also assessed at the
at-home examination and included as CVD risk factors.
History of diabetes mellitus was defined as fasting glucose
≥126 mg/dL, nonfasting glucose ≥200 mg/dL, or self-
reported oral hypoglycemic or insulin use. Furthermore, the
Physical Component Summary score of the 12-Item Short
Form Health Survey (SF-12)39 was used as an indicator of
overall physical health. The following health behaviors were
also assessed at the baseline interview and included in
analyses: cigarette smoking (current, past, never), alcohol use
(none, moderate, heavy, based on National Institute on Drug
Abuse categories for sex-specific high-risk drinking), physical
activity (never, at least once a week), and medication
adherence (perfect versus not perfect adherence, as mea-
sured by the Morisky Medication Adherence Scale40).
Analytic Approach
The end of follow-up for this study was December 31, 2012.
Follow-up time for each participant was calculated from the
date of his or her study in-home visit to the date of the first
CVD event, death, last telephone follow-up, or end of follow-
up. Consistent with prior research,12 participants were
classified into 3 groups reflecting psychosocial risk at
baseline: (1) those reporting no depressive symptoms (CES-
D <4) and without elevated levels of perceived stress (PSS
<5), (2) those reporting either elevated depressive symptoms
(CES-D ≥4) or perceived stress (PSS ≥5), and (3) those
reporting both elevated depressive symptoms and perceived
stress. Because of small sample sizes for those with elevated
depressive symptoms but without elevated perceived stress
(income ≥$35 000, n=230; income <$35 000, n=357), we
combined those with either elevated depressive symptoms or
stress into 1 group, as in previous research in the REGARDS
study.12 Sample sizes for those with elevated perceived stress
but without elevated depressive symptoms were n=2004 with
income ≥$35 000 and n=2143 with income <$35 000.
Primary analyses were stratified separately by annual house-
hold income at baseline (<$35 000 or ≥$35 000). A post hoc
supplemental analysis was also stratified by education
(graduating from high school versus not graduating).
Baseline characteristics of participants with and without
elevated psychosocial risk at baseline were compared using
chi-square tests, ANOVA (for normally distributed character-
istics), and Wilcoxon rank sum tests (for variables that were
not normally distributed). Using Poisson regression, we
calculated age-adjusted incidence rates separately for total
CVD, all-cause mortality, acute CHD, and cardiovascular death
events for each group of psychosocial risk within the strata of
SES per 1000 years of person-time. Sequentially adjusted Cox
proportional hazards regression models were constructed to
separately estimate the hazard ratios (HRs) for the association
between psychosocial risk groups and incident total CVD,
all-cause mortality, incident acute CHD, and cardiovascular
death. The initial model estimated the HRs of end points for
psychosocial risk groups, adjusted for age. Model 1 adjusted
for sex, race, geographic region of residence, and number of
people in the household. Model 2 adjusted for model
1 covariates plus systolic blood pressure, self-reported
antihypertensive medication use, total cholesterol, high-
density lipoprotein cholesterol, statin use, log-transformed
albumin:creatinine ratio, log-transformed high-sensitivity
C-reactive protein, estimated glomerular filtration rate, waist
circumference, and diabetes mellitus. Model 3 added adjust-
ments for cigarette smoking, alcohol use, physical activity, and
medication adherence. The final model for all-cause mortality
adjusted for model 3 covariates plus the Physical Component
Summary score of the SF-12. We also conducted formal tests
for interaction between psychosocial risk group and income
and education (separately) in the fully adjusted models in the
overall sample for each of the examined end points. The
assumptions of proportionality were tested by assessing
psychosocial risk group by log of follow-up time interactions in
the fully adjusted models and were met for all analyses.
Missing data in covariates were multiply imputed using
chained equations and sample bootstrapping in 10 data sets.
Analyses were conducted using SAS software version 9.4 (SAS
Institute) and Stata version 12 (StataCorp).
Results
Participant Characteristics
After excluding participants who were missing follow-up data
(n=489), baseline depressive symptom data (n=208), or
baseline perceived stress data (n=2), or who had prevalent
CVD at baseline (history of CHD, stroke, peripheral arterial
disease, or aortic aneurism; n=6826), a total of 22 658
participants composed the analytic sample for the current
study. At baseline, 45.4% (n=9020) had an annual household
income <$35 000. Overall, 12% of the REGARDS sample
(n=2768) declined to report annual income. We used multiple
imputation to replace missing data for these participants to
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preserve the original sample. In addition, 6.9% (n=1567) of
participants reported both elevated depressive symptoms and
stress, 24.0% (n=5441) reported either elevated depressive
symptoms or stress, and 69.1% (n=15 650) reported neither
elevated depressive symptoms nor stress. Furthermore, those
with low income were more likely to report both elevated
depressive symptoms and stress (10.9%) compared with
those with high income (3.5%; P<0.001).
Baseline characteristics for the 3 psychosocial risk groups,
stratified as a function of low versus high income (our primary
SES indicator), are presented in Table 1. Compared with
those with neither elevated depressive symptoms nor stress,
participants in the group with elevated depressive symptoms
and stress were more likely to be female, black, residents of
the stroke belt or buckle, and to have less than a high school
education; these differences were more pronounced for the
low- versus high-income group. Across both income groups,
participants with both elevated depressive symptoms and
stress were younger than those with neither psychosocial risk
factor, although those with low income had an older mean age
than those with high income in each psychosocial risk group.
Participants with low income had a greater cardiovascular risk
burden (as indicated by physiological, medical, and behavioral
risk factors) than those with high income. Furthermore, those
with elevated depressive symptoms and stress, in general,
had a worse physiological and behavioral risk profile than
those with neither elevated depressive symptoms nor stress.
Income, Psychosocial Risk, and Risks for Incident
Total CVD, Incident Acute CHD, Cardiovascular
Death, and All-Cause Mortality
Over a median of 7.0 years (interquartile range 5.4–8.3 years)
of follow-up, there were 1753 total CVD events. Even though
there were fewer participants in the low-income group than in
the high-income group, the low-income group accounted for a
greater share of events (1071 versus 682, respectively).
Participants with low income had higher cumulative incidence
of total CVD than those with high income, and those with low
income and both elevated depressive symptoms and stress
had the highest cumulative incidence of total CVD (Kaplan–
Meier survival curves are shown in Figure 1). Table 2 presents
age-adjusted incidence rates per 1000 person-years of follow-
up for the incident total CVD outcome for the 3 psychosocial
risk groups as a function of low and high income. Age-
adjusted incidence rates for those with low income were
substantially higher than for those with high income, and
greater psychosocial risk was associated with greater eleva-
tions in total CVD incidence only among those with low
income. Specifically, for participants with low income, those
with concurrent elevated depressive symptoms and stress
had the highest age-adjusted incidence rate per 1000 person-
years of follow-up (21.2), followed by those with either
elevated depressive symptoms or stress (16.2) and with
neither psychosocial risk factor (13.4).
Table 2 also presents the results of a series of increasingly
adjusted Cox proportional hazards regression models demon-
strating the associations between the different levels of
psychosocial risk with incident total CVD stratified by income.
For participants with low income, the co-occurrence of
elevated depressive symptoms and stress at baseline was
associated with significantly heightened risk of developing
total CVD compared with those with neither elevated
depressive symptoms nor stress in models that increasingly
adjusted for age (hazard ratio [HR] 1.53, 95% CI 1.05–1.39),
sociodemographics (model 1: HR 1.58, 95% CI 1.29–1.93),
physiological and medical CVD risk factors (model 2: HR 1.54,
95% CI 1.26–1.88), and health behaviors (model 3: HR 1.48,
95% CI 1.21–1.81). In other words, even when accounting for
a variety of potential confounders, participants with low
income and concurrent depressive symptoms and stress had
a nearly 50% higher risk of incident CVD events compared
with those with low income and neither elevated depressive
symptoms nor stress. Among those with annual household
income <$35 000, participants with either elevated depres-
sive symptoms or stress at baseline also had significantly
heightened risk of incident total CVD over follow-up compared
with those with neither psychosocial risk factor, although HRs
were not as high as those for participants with both elevated
depressive symptoms and stress. In contrast, for the high-
income group, the risks for participants with 1 psychosocial
risk factor versus both were not significantly different than
those for participants with neither psychosocial risk factor.
The psychosocial risk group by income interaction term had a
P value of 0.11.
Similar patterns emerged from separate models examining
income-stratified associations of psychosocial risk with
incident acute CHD and cardiovascular death (Table 2). Even
in models adjusting for sociodemographics, physiological and
medical CVD risk factors, and health behaviors, low-income
participants with elevated depressive symptoms and stress
had significantly elevated risk of acute CHD (model 3: HR
1.37, 95% CI 1.03–1.83) and cardiovascular death (model 3:
HR 1.54, 95% CI 1.13–2.08) compared with low-income
participants with no psychosocial risk factors at baseline. This
pattern of results was observed only for those with low
income and not for those with high income.
Over the course of follow-up, there were 2568 deaths due
to all causes. Cumulative incidence of all-cause mortality was
higher for those with low (versus high) income and highest for
those with low income and 1 or both psychosocial risk factors
(Kaplan–Meier survival curves shown in Figure 2). The age-
adjusted incidence rates per 1000 person-years of follow-up
for all-cause mortality for participants with low income were
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Table 1. Baseline Characteristics of REGARDS Participants Free of CVD With Neither, Either, or Concurrent Elevated Depressive
Symptoms and Perceived Stress Shown Separately for High and Low Income
Characteristic






























Age, y, mean (SD) 62.18.5 60.68.9 58.08.2 <0.001 66.99.0 65.49.7 62.29.6 <0.001
Female, n (%) 3740 (45.3) 1338 (59.9) 260 (68.4) <0.001 3535 (63.9) 1777 (71.1) 750 (76.2) <0.001
Black, n (%) 2529 (30.6) 800 (35.8) 134 (35.3) <0.001 2786 (50.3) 1445 (57.8) 600 (61.0) <0.001
Did not graduate from
high school, n (%)
187 (2.3) 64 (2.9) 17 (4.5) 0.01 921 (16.6) 544 (21.8) 280 (28.5) <0.001
Number of people in the
household, median (IQR)
2 (2–3) 2 (2–3) 2 (2–3) <0.001 2 (1–2) 2 (1–2) 2 (1–3) <0.001
Lives alone, n (%) 1296 (15.7) 372 (16.7) 83 (21.8) 0.005 2270 (41.0) 990 (39.6) 371 (37.7) 0.11
Region 0.09 <0.001
Stroke belt, n (%) 2599 (31.5) 750 (33.6) 121 (31.8) 2052 (37.1) 939 (37.6) 407 (41.4)
Stroke buckle, n (%) 1738 (21.1) 472 (21.1) 95 (25.0) 1074 (19.4) 545 (21.8) 230 (23.4)
Non–stroke belt
or buckle, n (%)




94.914.8 94.615.8 96.016.4 0.22 95.916.0 96.616.1 98.817.0 <0.001




50.67.8 47.810.4 45.512.1 <0.001 47.09.9 43.111.2 39.311.9 <0.001
Systolic blood pressure,
mm Hg, mean (SD)
125.015.1 123.615.6 122.515.9 <0.001 129.616.9 129.117.5 129.318.1 0.55
Total cholesterol,
mg/dL, mean (SD)
193.937.1 195.537.6 196.536.5 0.10 196.140.1 197.542.1 199.143.3 0.08
High-density lipoprotein,
mg/dL, mean (SD)
52.016.3 53.516.4 54.117.6 0.0002 52.916.1 53.415.9 53.216.0 0.50
Estimated glomerular
filtration rate <60, n (%)
482 (6.0) 124 (5.8) 19 (5.2) 0.75 633 (12.0) 299 (12.6) 72 (7.7) 0.002
High-sensitivity C-reactive
protein, mg/L, median (IQR)
1.7 (0.8–4.0) 2.1 (0.9–4.6) 2.5 (1.2–6.2) <0.001 2.5 (1.1–5.5) 2.8 (1.2–6.5) 3.5 (1.3–7.8) <0.001
Albumin:creatinine
ratio >30 mg/g, n (%)
775 (9.5) 224 (10.4) 32 (8.8) 0.37 811 (15.4) 406 (17.2) 161 (17.5) 0.06
Medications
Antihypertensive
medication use, n (%)
3391 (41.3) 920 (41.7) 164 (43.6) 0.67 2863 (52.3) 1388 (56.1) 576 (59.3) <0.001
Statin use, n (%) 2114 (25.7) 517 (23.1) 91 (24.1) 0.04 1319 (23.9) 639 (25.6) 238 (24.3) 0.24
Behavioral risk factors
Smoking <0.001 <0.001
Current, n (%) 851 (10.3) 265 (11.9) 88 (23.3) 856 (15.5) 455 (18.2) 276 (28.1)
Never, n (%) 4003 (48.6) 1140 (51.3) 163 (43.1) 2545 (46.1) 1149 (46.1) 450 (45.9)
Past, n (%) 3381 (41.1) 818 (36.8) 127 (33.6) 2116 (38.4) 890 (35.7) 255 (26.0)
Continued
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staggering, and they were progressively higher as a function
of greater psychosocial risk: 19.2 for those with neither
elevated depressive symptoms nor stress, 22.8 for those with
either elevated depressive symptoms or stress, and 28.4 for
those with both elevated depressive symptoms and stress
(Table 2). Similar to the total CVD analysis, low-income
participants with elevated depressive symptoms and stress
had increased risk of all-cause mortality compared with low-
income participants with neither elevated depressive symp-
toms nor stress (HR 1.33 [95% CI 1.13–1.56] in the final
model adjusting for sociodemographics, physiological and
medical CVD risk factors, health behaviors, and the Physical
Health Component score of the SF-12). HRs for all-cause
mortality for low-income participants with either elevated
depressive symptoms or stress compared with low-income
participants with neither psychosocial risk factor were also
elevated, although the HR was not significantly different from
1 in the final model (Table 2). Unlike the total CVD analysis,
there was some evidence that psychosocial risk factors were
also associated with increased risk of all-cause mortality for
high-income participants. High-income participants with 1 or
both psychosocial risk factors had significantly elevated risk
Figure 1. Kaplan–Meier survival curves for incident total cardiovascular disease (CVD) in participants with low and high income. Incident CVD

































Alcohol use 0.001 0.62
Heavy, n (%) 439 (5.4) 105 (4.8) 21 (5.6) 181 (3.3) 67 (2.8) 31 (3.3)
Moderate, n (%) 3622 (44.5) 895 (40.7) 141 (37.9) 1371 (25.2) 595 (24.4) 233 (24.4)
None, n (%) 4074 (50.1) 1197 (54.5) 210 (56.5) 3895 (71.5) 1774 (72.8) 689 (72.3)
Physical inactivity, n (%) 2125 (26.0) 716 (32.5) 153 (40.8) <0.001 1896 (34.8) 995 (40.3) 458 (47.1) <0.001
Medication
nonadherence, n (%)
1950 (26.8) 632 (31.7) 141 (40.6) <0.001 1342 (26.9) 741 (33.1) 367 (40.6) <0.001
Elevated depressive symptoms were defined as a score ≥4 on the Center for Epidemiologic Studies–Depression scale, and elevated perceived stress was defined as a score ≥5 on the
Perceived Stress Scale. P values from chi square, ANOVA tests. The stroke belt was defined as the states of Alabama, Arkansas, Louisiana, Mississippi, Tennessee, and the noncoastal
regions within the states of North Carolina, South Carolina and Georgia. The stroke buckle was defined as coastal regions within the states of North Carolina, South Carolina, and Georgia.
Diabetes mellitus was defined as fasting blood glucose ≥126 or random glucose >200 mL/dL, or oral hypoglycemic or insulin use. CVD was defined as baseline coronary heart disease,
stroke, periphery artery disease, or aortic aneurism. CVD indicates cardiovascular disease; IQR, interquartile range; REGARDS, Reasons for Geographical and Racial Differences in Stroke;
SF-12, 12-Item Short Form Health Survey.
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of all-cause mortality compared with high-income participants
with neither psychosocial risk factor in models adjusting for
sociodemographics and physiological and medical CVD risk
factors (models 1 and 2 are described in Table 2; participants
with one psychosocial risk factor also had significantly
elevated risk in model 3). However, the HRs for the groups
with 1 or both psychosocial risk factors were not significantly
>1 in the final model that additionally adjusted for the
Physical Component Summary score of the SF-12 (Table 2).
Education, Psychosocial Risk, and Risks for
Incident Total CVD, Incident Acute CHD,
Cardiovascular Death, and All-Cause Mortality
Table S1 shows the results of analyses examining the
association of depressive symptoms and perceived stress
with incident total CVD, incident acute CHD, cardiovascular
death, and all-cause mortality separately for those with low
and high education (our secondary SES indicator). Notably,
the same pattern of associations between the combination of
elevated depressive symptoms and stress and increased risk
of incident CVD and mortality primarily for those with low (and
not high) SES was not observed when we used education
rather than income as the SES indicator. In general,
psychosocial risk factors were associated with increased risk
of incident total CVD and all-cause mortality in those with
both low and high education.
Sensitivity Analyses for Definition of Elevated
Perceived Stress
Results of sensitivity analyses using a PSS score ≥8
(corresponding to the 95th percentile) to indicate elevated
levels of perceived stress are presented in Tables S2 and S3.
The pattern of results was highly similar when using this
higher cutoff for elevated stress to create the psychosocial
risk groups.
Discussion
In a major national cohort study using population-based
sampling methods, we demonstrated that the combination of
elevated depressive symptoms and perceived stress was
associated with increased risk of first-onset CVD events,
including nonfatal myocardial infarction, nonfatal stroke, and
cardiovascular death in low- but not high-income participants.
Our findings add to a growing body of work indicating that
psychosocial factors related to CVD risk are most deleterious
for those with low income.21,24,25 Furthermore, our results
suggest that it is the combination of psychosocial risk factors
that is associated with the greatest vulnerability to poor
cardiovascular health in low-income persons. The comorbidity
of elevated depressive symptoms and stress in those with low
income was associated with higher incidence of CVD than
either psychosocial risk factor alone, although those with 1
risk factor had higher incidence of CVD than those with
neither elevated depressive symptoms nor stress. Notably,
these findings were observed even when adjusting for a
variety of potential confounders, including sociodemograph-
ics, physiological and medical CVD risk factors, and health
behaviors.
SES and psychosocial factors, including depressive symp-
toms, psychological distress, and perceived stress, have been
increasingly recognized as risk factors for CVD.3,4,7 Only
recently have researchers begun to appreciate the informa-
tion to be learned by considering both sets of factors
simultaneously to better identify persons at elevated risk of
poor cardiovascular outcomes and mortality.21,23–25,41
Whereas most prior work in this area has focused on the
joint contributions of SES and a single psychosocial risk factor
(eg, depression, stress), our research emphasized the impor-
tance of considering a confluence of psychosocial risk factors,
in addition to SES, to identify those who are most vulnerable
to CVD. Our findings extend results from persons with a
history of CHD10 and diabetes mellitus,12 suggesting that the
comorbidity of elevated depressive symptoms and stress is
most pernicious for cardiovascular risk. Interestingly, although
the combination of elevated depressive symptoms and stress
was associated with significantly elevated risk of all-cause
mortality in fully adjusted models only for those with low
income, effect sizes for the psychosocial risk groups were
relatively similar in both income groups. Differences across
income groups might emerge in an analysis with more cases
of all-cause mortality and greater statistical power, thereby
precluding definitive conclusions about no effect of income
with respect to the relationship of psychosocial risk and all-
cause mortality. Nevertheless, our results suggest that among
persons with no history of CVD at baseline, elevated
depressive symptoms and stress may be particularly associ-
ated with risk of incident CVD in those with low income but
that the confluence of psychosocial risk factors may be linked
to all-cause mortality regardless of individual income. Addi-
tional research is needed to replicate these findings and to
probe mechanisms underlying this apparent discrepancy.
Why might the combination of elevated depressive symp-
toms and stress be particularly associated with CVD risk in
those with low but not high income? Consistent with the
reserve capacity model,20,22 persons with low (versus high)
income may have fewer resources on which to draw and may
be exposed to taxing situations that require resources for
coping more frequently as a function of their position in
society. When faced with a psychosocial perfect storm13 of
both elevated depressive symptoms and stress, persons with
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Table 2. Association of Concurrent Depressive Symptoms and Perceived Stress With Incident Total CVD, Acute Coronary
Heart Disease, Cardiovascular Death, and All-Cause Mortality Shown Separately for REGARDS Participants With High and Low
Income
Variable
























Total CVD (incident nonfatal MI, nonfatal stroke, or cardiovascular death)
Number of events 524 144 14 636 312 123
Age-adjusted IR/1000
person-years (95% CI)
6.8 (6.1–7.5) 7.9 (6.6–9.4) 5.2 (3.0–9.2) 13.4 (12.3–14.7) 16.2 (14.3–18.3)*,§ 21.2 (17.6–25.7)‡,§
Age-adjusted HR (95% CI) Ref 1.16 (0.96–1.41) 0.77 (0.43–1.37) Ref 1.20 (1.05–1.38)§ 1.53 (1.05–1.39)§
Model 1 HR (95% CI) Ref 1.24 (1.03–1.51)§ 0.90 (0.50–1.60) Ref 1.23 (1.07–1.42)§ 1.58 (1.29–1.93)§
Model 2 HR (95% CI) Ref 1.18 (0.97–1.42) 0.85 (0.48–1.51) Ref 1.21 (1.05–1.39)§ 1.54 (1.26–1.88)§
Model 3 HR (95% CI) Ref 1.17 (0.97–1.42) 0.78 (0.44–1.39) Ref 1.20 (1.04–1.38)§ 1.48 (1.21–1.81)§
Psychosocial risk and income
interaction, P valuek
0.11§
Acute coronary heart disease
Number of events 298 77 7 302 151 59
Age-adjusted IR/1000
person-years (95% CI)
4.0 (3.5–5.6) 4.4 (3.5–5.6) 2.6 (1.2–5.8) 6.9 (6.1–7.8) 8.3 (7.0–9.9) 9.9 (7.6–13.0)*,§
Age-adjusted HR (95% CI) Ref 1.08 (0.84–1.40) 0.66 (0.30–1.46) Ref 1.20 (0.99–1.47) 1.45 (1.09–1.93)§
Model 1 HR (95% CI) Ref 1.19 (0.91–1.54) 0.80 (0.36–1.77) Ref 1.24 (1.02–1.52)§ 1.50 (1.12–1.99)§
Model 2 HR (95% CI) Ref 1.11 (0.86–1.43) 0.74 (0.33–1.64) Ref 1.21 (1.00–1.48) 1.44 (1.08–1.92)§
Model 3 HR (95% CI) Ref 1.10 (0.85–1.43) 0.68 (0.31–1.52) Ref 1.21 (0.99–1.47) 1.37 (1.03–1.83)§




Number of events 160 48 4 289 147 54
Age-adjusted IR/1000
person-years (95% CI)
1.7 (1.4–2.2) 2.3 (1.7–3.2) 1.2 (0.4–3.7) 4.9 (4.2–5.6) 6.2 (5.2–7.5)*,§ 7.4 (5.5–7.4)*,§
Age-adjusted HR (95% CI) Ref 1.30 (0.94–1.81) 0.78 (0.23–2.63) Ref 1.26 (1.03–1.54)§ 1.59 (1.18–2.14)§
Model 1 HR (95% CI) Ref 1.34 (0.96–1.87) 0.87 (0.26–2.91) Ref 1.27 (1.04–1.56)§ 1.59 (1.18–2.15)§
Model 2 HR (95% CI) Ref 1.23 (0.88–1.72) 0.77 (0.24–2.53) Ref 1.23 (1.002–1.50)§ 1.61 (1.19–2.17)§
Model 3 HR (95% CI) Ref 1.21 (0.86–1.69) 0.71 (0.21–2.36) Ref 1.22 (0.99–1.49) 1.54 (1.13–2.08)§




Number of events 618 183 27 1043 506 191
Age-adjusted IR/1000
person-years (95% CI)
6.4 (5.8–7.2) 8.2 (7.0–9.7)*,§ 8.7 (5.8–13.1) 19.2 (17.8–20.7) 22.8 (20.6–25.3)†,§ 28.4 (24.3–33.3)‡,§
Age-adjusted HR (95% CI) Ref 1.31 (1.10–1.55)§ 1.47 (0.98–2.21) Ref 1.21 (1.09–1.35)§ 1.54 (1.32–1.80)§
Model 1 HR (95% CI) Ref 1.34 (1.13–1.59)§ 1.64 (1.09–2.48)§ Ref 1.24 (1.12–1.39)§ 1.61 (1.37–1.88)§
Model 2 HR (95% CI) Ref 1.26 (1.06–1.50)§ 1.56 (1.03–2.26)§ Ref 1.22 (1.09–1.36)§ 1.61 (1.37–1.89)§
Continued
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low income may be less able to cope effectively with
concurrent psychosocial challenges, and this may negatively
affect cardiovascular health by both behavioral and physio-
logical pathways. As observed in our sample (Table 1),
persons with low income may be more likely to engage in
poor health behaviors that may contribute to risk for CVD (eg,
smoking, physical inactivity, overeating, and poor adherence
to medical treatment regimens).8,42 In addition, those with
low income have been characterized by a lack of physiological
reserve.20,43 Consequently, when faced with psychosocial
stress, those with low income may have exaggerated
physiological responses (eg, elevated sympathetic nervous
system activity and hypothalamic–pituitary–adrenal axis dys-
regulation43,44) that can have negative downstream effects for
cardiovascular health, particularly when activated in a chronic
manner.
The nature of stress may differ for persons with low versus
high income. Elevated perceived stress for those with low
income may reflect stress related to concerns with significant
implications for one’s livelihood (eg, not making rent or
Table 2. Continued
Variable
























Model 3 HR (95% CI) Ref 1.25 (1.05–1.48)§ 1.40 (0.92–2.12) Ref 1.21 (1.08–1.35)§ 1.55 (1.31–1.82)§





IRs and HRs for the psychosocial risk groups. Model 1 adjusts for age, sex, race, geographic region, and number of people in the household. Model 2 adjusts for model 1 covariates plus
systolic blood pressure, self-reported antihypertensive medication use, total cholesterol, high-density lipoprotein cholesterol, statin use, log-transformed albumin:creatinine ratio, log-
transformed high-sensitivity C-reactive protein, estimated glomerular filtration rate, waist circumference, and diabetes mellitus. Model 3 adjusts for model 2 covariates plus cigarette
smoking, alcohol use, physical activity, and medication adherence. The final model for all-cause mortality adjusts for model 3 covariates plus the PCS of the SF-12. Missing data in
covariates were imputed using chain equations in 10 data sets with sample bootstrapping. CVD indicates cardiovascular disease; HR, hazard ratio; IR, incidence rate; MI, myocardial
infarction; PCS, Physical Component Summary score; Ref, reference value; REGARDS, Reasons for Geographical and Racial Differences in Stroke; SF-12, 12-Item Short Form Health Survey.
*Incidence rate is significantly different compared with the group with no depression and no stress, P<0.05.
†Incidence rate is significantly different compared with the group with no depression and no stress, P≤0.01.
‡Incidence rate is significantly different compared with the group with no depression and no stress, P≤0.001.
§Significant at P<0.05.
kInteraction term P value from the overall (not stratified) final model.
Figure 2. Kaplan–Meier survival curves for all-cause mortality in participants with low and high income. REGARDS indicates Reasons for
Geographical and Racial Differences in Stroke.
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mortgage payments, food insecurity), whereas elevated
perceived stress for those with high income may reflect
challenges that have less impact on quality of life (eg, stress
related to interactions with a coworker rather than stress over
being unemployed). In addition, compared with those with
high income, persons with low income may be more likely to
be exposed to environmental conditions (eg, crime, high
population density) that contribute to a state of chronic
stress, which takes a toll on physical health.42 Furthermore,
the stress faced by those with low (versus high) income may
be more likely to be perceived as unpredictable, uncontrol-
lable, and unmanageable. In both animal and human research,
the experience of uncontrollable stress has been shown to
induce physiological changes (eg, hypothalamic–pituitary–
adrenal axis activation) that can have negative downstream
consequences for cardiovascular health; in contrast, stress
that is perceived as being controllable does not trigger such
physiological responses to the same degree.45 Consequently,
the types of stress faced by those with low income may be
particularly detrimental for health, especially for persons who
are depressed. It is of interest to examine this notion
empirically in future research.
Interestingly, we found that the combination of elevated
depressive symptoms and stress was associated with
increased risk of CVD incidence and all-cause mortality
primarily for those with low SES when we stratified analyses
based on income and not on education. When stratifying on
low versus high education, elevated depressive symptoms and
stress were associated with the greatest elevation in risk for
incident total CVD and all-cause mortality in both education
groups. A possible explanation for these findings is that
income may be a better indicator of life quality and resources
than education. Indeed, researchers have highlighted how
educational attainment does not necessarily translate into
earnings potential,20 and one can imagine a situation in which
a person is educated (eg, with a high school or even a college
degree) and yet not financially comfortable. This scenario is
disproportionately true for black persons (particularly black
women). Black women earn the least among other college
degree holders,46 and compared with white applicants, black
applicants are less likely to be offered jobs, even when they
have college degrees from prestigious universities.47 These
findings highlight an important disparity between educational
attainment and earning potential for certain groups of people.
These results are also consistent with the recent finding from
the REGARDS study that high education was not able to offset
risk for CHD associated with low income in adults aged
<65 years.33 Although education and income are indicators of
SES that are robustly associated with CVD outcomes,3
income may be a better factor for identifying persons who
may be most susceptible to the effects of psychosocial risk
factors on CVD health. Additional research is needed to
determine whether this finding can be generalized beyond the
REGARDS study.
Demonstrating a differential impact of concurrent psy-
chosocial risk factors on the incidence of CVD events and
mortality for certain persons has the potential to inform
targeted efforts for allocating resources to offset risk. Both
the American Heart Association 2020 Impact Goals2 and the
US Department of Health and Human Services “Million
Hearts” initiative48 identified reducing CVD incidence and
mortality as critical health goals for the United States. We
believe that our findings have several implications for policy
and for directing health care prevention resources in an age
of targeted medicine. First, our finding that the combination
of elevated depressive symptoms and stress was associated
with the greatest elevation in risk for developing total CVD
and all-cause mortality compared with having 1 or no
psychosocial risk factors demonstrates the importance of
taking a number of psychosocial factors into consideration
when assessing cardiovascular risk, most markedly among
those with low income. Screening for psychosocial risk
factors can be accomplished easily and quickly in health
care and community settings with short screening question-
naires.29,32 Our results suggest the value of screening for
both elevated depressive symptoms and stress—not just
one or the other—to identify persons at the greatest
cardiovascular risk, and our findings indicate that persons
with low income may predominantly benefit from such
psychosocial screening. Second, our findings suggest that
low-income persons do not need to be at or below the
poverty level to experience the deleterious health effects of
a confluence of psychosocial risk factors. Notably, our
definition of low income was an annual household income <
$35 000, which was derived from the data and is signifi-
cantly higher than the poverty level. The Federal Poverty
Level for a family of 4 was $18 400 in 2003 and $20 650 in
2007 (the years of the baseline period for the REGARDS
study). Although this finding warrants replication in other
modern samples, it provides preliminary evidence that
persons with low household income well above the Federal
Poverty Level may be particularly vulnerable to the effects of
psychosocial risk factors for poor physical health and may
benefit from screening and prevention efforts. More research
is needed to better understand the mechanisms by which
concurrent psychosocial risk factors contribute to poor
health outcomes in low-income persons to best tailor
prevention and intervention efforts for this population (eg,
described by Wells and Miranda49). In the meantime, our
study provides important information for population health
managers by supporting targeted screening of the population
with low income.
Despite these implications for health policy, our study has
several limitations that merit acknowledgement. First, the
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REGARDS study included an observational cohort and was not
designed to derive causal links. Nevertheless, by using
psychosocial and SES data from the baseline assessment
and by limiting our sample to those without a history of CVD
at baseline, we were able to ensure that our predictors
occurred prior to our outcomes of interest. Second, we did
not adjust for the competing risk of mortality in the incident
CVD analyses, and that approach could have introduced
potential bias, particularly for low-income participants.
However, prior studies of incident CVD in the REGARDS
study obtained similar results with and without a competing
risk approach.50 Third, depressive symptoms, perceived
stress, annual household income, education, and health
behaviors were assessed by self-report at only 1 point in
time (the baseline assessment), and depressive symptoms
and perceived stress were measured with short screening
questionnaires. Consequently, we were unable to assess
participants’ psychosocial risk immediately preceding CVD
incidence or mortality or to investigate how changes in
psychosocial risk or SES over time relate to risk of incident
CVD and mortality. Furthermore, by using these brief
measures, we were not able to comprehensively assess the
complex constructs of depression, stress, and SES. Additional
research that incorporates multiple measures of psychosocial
risk and SES over time and that includes methods that go
beyond self-report (eg, objective measures of SES, diagnostic
interviews for depression, life stress interviews) will add
greater precision to our understanding of how a confluence of
psychosocial risk factors and SES contributes to risk of CVD
and mortality. Moreover, assessing potential underlying
mechanisms in the context of a combination of elevated
depressive symptoms and stress may shed light on how
cardiovascular risk unfolds. Fourth, because of the design of
the REGARDS study, only white and black participants were
included in our sample. Additional research is needed to
examine whether findings generalize to participants of other
racial and ethnic groups. Because of low statistical power, we
did not investigate whether the associations of the psychoso-
cial risk groups with CVD risk among those with low (versus
high) SES differed for black and white participants. This topic
is important for future study in larger samples, particularly
given racial differences in depressive symptoms, perceived
stress, SES, and CVD outcomes.
Even with these limitations, we believe our study has a
number of strengths and makes a unique and notable
contribution to the literature. We used longitudinal data from
a large national cohort with population-based sampling
methods, and we predicted CVD and mortality events that
were adjudicated by physician-led teams. Furthermore, we
accounted for a number of potential confounders in our
analyses, several of which were assessed with an in-home
examination.
Conclusions
Our study suggests that taking a confluence of psychosocial
risk factors and SES into consideration may hold promise for
working to offset CVD risk. In an age of precision medicine
and population health management, screening for a combi-
nation of elevated depressive symptoms and stress in low-
income persons may help identify those at increased risk of
incident CVD and mortality. Going forward, it would be of
interest to identify these persons not only in health care
settings but also in community settings and to pinpoint the
most effective interventions to offset risk in this population.
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Table S1. Association of concurrent depressive symptoms (CESD≥4) and perceived stress (PSS≥5) with incident total cardiovascular disease, acute coronary heart disease, 
cardiovascular death, and all-cause mortality, separately for REGARDS participants with high or low education. Incidence rates and hazard ratios for the psychosocial risk groups. 
  
  






















  TOTAL CVD (Incident Nonfatal MI, Nonfatal stroke, or Cardiovascular death) 
N of events 986 359 89 174 97 47 
Age-adjusted IR./1000 person-years (95% CI) 8.7(8.1-9.4) 10.6(9.5-11.8)** 12.3(10.0-12.3)** 18.5(15.8-21.8) 21.9(17.8-26.8) 27.0(20.3-35.9)* 
Age-adjusted HR (95% CI) Ref 1.22(1.08-1.37) 1.42(1.15-1.77) Ref 1.19(0.93-1.53) 1.48(1.07-2.05) 
Model 1 HR (95% CI) Ref 1.23(1.09-1.40) 1.42(1.14-1.78) Ref 1.23(0.95-1.58) 1.58(1.13-2.21) 
Model 2 HR (95% CI) Ref 1.20(1.06-1.35) 1.34(1.07-1.67) Ref 1.19(0.92-1.54) 1.62(1.16-2.26) 
Model 3 HR (95% CI) Ref 1.18(1.05-1.34) 1.27(1.01-1.58) Ref 1.21(0.94-1.57) 1.58(1.13-2.22) 
Psychosocial risk x education interaction P-value1 0.49 
 ACUTE CORONARY HEART DISEASE 
N of events 509 177 45 92 51 21 
Age-adjusted IR./1000 person-years (95% CI) 4.7(4.3-5.2) 5.4(4.7-6.3) 6.4(4.7-8.5) 10.3(8.3-12.7) 11.6(8.8-15.3) 11.4(7.5-17.5) 
Age-adjusted HR (95% CI) Ref 1.16(0.97-1.37) 1.36(1.00-1.84) Ref 1.14(0.81-1.61) 1.14(0.71-1.84) 
Model 1 HR (95% CI) Ref 1.22(1.03-1.45) 1.45(1.06-1.98) Ref 1.21(0.85-1.71) 1.23(0.75-2.00) 
Model 2 HR (95% CI) Ref 1.18(0.99-1.40) 1.35(0.99-1.85) Ref 1.15(0.81-1.64) 1.20(0.73-1.96) 
Model 3 HR (95% CI) Ref 1.16(0.98-1.39) 1.28(0.94-1.76) Ref 1.17(0.82-1.66) 1.17(0.71-1.92) 
Psychosocial risk x education interaction P-value1 0.98 
  CARDIOVASCULAR DEATH 
N of events 357 145 39 92 50 19 
Age-adjusted IR./1000 person-years (95% CI) 2.6(2.3-2.9) 3.4(2.8-4.1)** 4.5(3.3-6.2)*** 8.2(6.5-10.4) 9.5(7.1-12.8) 9.2(5.9-14.6) 
Age-adjusted HR (95% CI) Ref 1.36(1.12-1.64) 1.81(1.30-2.52) Ref 1.20(0.85-1.69) 1.18(0.72-1.94) 
Model 1 HR (95% CI) Ref 1.30(1.07-1.59) 1.66(1.18-2.32) Ref 1.22(0.86-1.73) 1.25(0.86-1.73) 
Model 2 HR (95% CI) Ref 1.27(1.04-1.54) 1.60(1.14-2.25) Ref 1.17(0.82-1.66) 1.30(0.78-2.18) 
Model 3 HR (95% CI) Ref 1.24(1.02-1.51) 1.49(1.05-2.08) Ref 1.17(0.82-1.67) 1.29(0.77-2.17) 
Psychosocial risk x education interaction P-value1 0.77 








  ALL CAUSE MORTALITY 
N of events 1,366 529 144 295 160 74 
Age-adjusted IR./1000 person-years (95% CI) 10.2(9.6-10.9) 
13.0 
(11.9-14.3)*** 
17.3(14.6-20.4)*** 28.0(24.7-31.8) 32.1(27.3-37.7) 37.2(29.6-46.8)* 
Age-adjusted HR (95% CI) Ref 1.31(1.19-1.45) 1.78(1.50-2.11) Ref 1.20(0.99-1.45) 1.41(1.09-1.83) 
Model 1 HR (95% CI) Ref 1.29(1.17-1.43) 1.68(1.41-2.00) Ref 1.22(1.01-1.50) 1.50(1.16-1.96) 
Model 2 HR (95% CI) Ref 1.26(1.14-1.39) 1.64(1.38-1.96) Ref 1.15(0.94-1.40) 1.55(1.19-2.03) 
Model 3 HR (95% CI) Ref 1.23(1.11-1.36) 1.52(1.27-1.81) Ref 1.19(0.97-1.44) 1.56(1.19-2.04) 
+SF-12 PCS HR (95% CI) Ref 1.12(1.01-1.24) 1.31(1.10-1.57) Ref 1.12(0.92-1.37) 1.36(1.03-1.79) 
Psychosocial risk x education interaction P-value1 0.87 
Abbreviations: CI=confidence interval. CVD=cardiovascular disease. IR=incidence rate. HR=hazard ratio. MI=myocardial infarction. PCS=Physical Component Summary score of 
the SF-12. 
 
*Incidence rate is significantly different, compared to the “No depression/no stress group,” p<.05 
**Incidence rate is significantly different, compared to the “No depression/no stress group,” p≤.01 
***Incidence rate is significantly different, compared to the “No depression/no stress group,” p ≤.001 
 
Model 1 adjusts for age, sex, race, geographic region, number of people in household 
Model 2 adjusts for Model 1 covariates plus systolic blood pressure, self-reported antihypertensive medication use, total cholesterol, HDL-cholesterol, statin use, log-transformed 
albumin to creatinine ratio, log-transformed high-sensitivity C-reactive protein, estimated glomerular filtration rate, waist circumference, diabetes  
Model 3 adjusts for Model 2 covariates plus cigarette smoking, alcohol use, physical activity, medication adherence  
Final model for all-cause mortality adjusts for Model 3 covariates plus the Physical Component Summary score of the SF-12 
1Interaction term p-value from the overall (not stratified) final model 
 
Missing data in covariates imputed using chain equations in 10 datasets with sample bootstrapping 
 



















Table S2. Association of concurrent depressive symptoms (CESD≥4) and perceived stress (PSS≥8) with incident total cardiovascular disease, acute coronary heart disease, 
cardiovascular death, and all-cause mortality, separately for REGARDS participants with high or low income. Incidence rates and hazard ratios for the psychosocial risk groups. 
  
  
























  TOTAL CVD (Incident Nonfatal MI, Nonfatal stroke, or Cardiovascular death) 
N of events 635 39 9 838 162 70 
Age-adjusted IR./1000 person-years (95% CI) 7.0(6.4-7.7) 6.1(4.3-8.6) 7.0(3.5-14.1) 14.2(13.1-15.3) 16.3(13.7-19.4) 22.3(17.4-28.5)*** 
Crude HR (95% CI) Ref 0.82(0.58-1.16) 0.71(0.34-1.45) Ref 1.08(0.91-1.28) 1.17(0.92-1.50) 
Model 1 HR (95% CI) Ref 1.01(0.72-1.42) 1.10(0.54-2.26) Ref 1.19(1.00-1.42) 1.54(1.20-1.98) 
Model 2 HR (95% CI) Ref 0.97(0.69-1.36) 0.95(0.46-1.93) Ref 1.16(0.98-1.38) 1.52(1.18-1.95) 
Model 3 HR (95% CI) Ref 0.96(0.68-1.35) 0.83(0.41-1.70) Ref 1.15(0.97-1.36) 1.42(1.11-1.83) 
 ACUTE CORONARY HEART DISEASE 
N of events 360 19 4 399 82 31 
Age-adjusted IR./1000 person-years (95% CI) 4.1(3.6-4.6) 3.2(2.0-5.1) 3.5(1.3-9.3) 7.2(6.5-8.1) 8.7(6.9-11.1) 9.3(6.4-13.5) 
Crude HR (95% CI) Ref 0.70(0.44-1.12) 0.62(0.23-1.68) Ref 1.16(0.91-1.47) 1.06(0.74-1.54) 
Model 1 HR (95% CI) Ref 0.88(0.55-1.42) 0.96(0.35-2.56) Ref 1.24(0.98-1.58) 1.28(0.88-1.86) 
Model 2 HR (95% CI) Ref 0.84(0.52-1.35) 0.77(0.29-2.12) Ref 1.22(0.96-1.56) 1.23(0.85-1.79) 
Model 3 HR (95% CI) Ref 0.82(0.51-1.33) 0.70(0.26-1.90) Ref 1.21(0.95-1.54) 1.15(0.79-1.68) 
  CARDIOVASCULAR DEATH 
N of events 195 14 3 377 80 35 
Age-adjusted IR./1000 person-years (95% CI) 1.8(1.5-2.2) 1.7(1.0-3.2) 2.5(0.8-7.8) 5.1(4.5-5.8) 6.2(4.8-8.1) 8.8(6.1-12.7)** 
Crude HR (95% CI) Ref 0.94(0.51-1.71) 0.93(0.28-3.04) Ref 1.18(0.92-1.51) 1.28(0.90-1.83) 
Model 1 HR (95% CI) Ref 1.13(0.62-2.06) 1.52(0.47-4.94) Ref 1.29(1.01-1.66) 1.74(1.22-2.49) 
Model 2 HR (95% CI) Ref 1.00(0.54-1.85) 1.19(0.37-3.81) Ref 1.23(0.96-1.58) 1.79(1.25-2.56) 
Model 3 HR (95% CI) Ref 0.96(0.52-1.79) 1.08(0.33-3.49) Ref 1.21(0.94-1.55) 1.68(1.17-2.42) 
  ALL CAUSE MORTALITY 
N of events 745 67 16 1,337 278 125 
Age-adjusted IR./1000 person-years (95% CI) 6.6(6.0-7.3) 8.8(6.8-11.5)* 11.5(6.8-19.4)* 19.5(18.3-20.9) 24.7(21.6-28.4)** 34.1(28.2-41.2)*** 








Crude HR (95% CI) Ref 1.27(0.98-1.65) 1.20(0.71-2.02) Ref 1.19(1.05-1.36) 1.33(1.11-1.60) 
Model 1 HR (95% CI) Ref 1.50(1.15-1.95) 2.02(1.21-3.39) Ref 1.35(1.19-1.55) 1.84(1.53-2.22) 
Model 2 HR (95% CI) Ref 1.39(1.07-1.81) 1.78(1.06-2.00) Ref 1.30(1.13-1.48) 1.88(1.56-2.27) 
Model 3 HR (95% CI) Ref 1.34(1.03-1.75) 1.55(0.92-2.60) Ref 1.26(1.10-1.44) 1.75(1.45-2.12) 
+SF-12 PCS HR (95% CI) Ref 1.25(0.96-1.64) 1.41(0.83-2.37) Ref 1.14(1.00-1.31) 1.50(1.24-1.82) 
Abbreviations: CI=confidence interval. CVD=cardiovascular disease. IR=incidence rate. HR=hazard ratio. MI=myocardial infarction. PCS=Physical Component Summary score 
of the SF-12 
 
*Incidence rate is significantly different, compared to the “No depression/no stress group,” p<.05 
**Incidence rate is significantly different, compared to the “No depression/no stress group,” p≤.01 
***Incidence rate is significantly different, compared to the “No depression/no stress group,” p ≤.001 
 
Model 1 adjusts for age, sex, race, geographic region, number of people in household 
Model 2 adjusts for Model 1 covariates plus systolic blood pressure, self-reported antihypertensive medication use, total cholesterol, HDL-cholesterol, statin use, log-transformed 
albumin to creatinine ratio, log-transformed high-sensitivity C-reactive protein, estimated glomerular filtration rate, waist circumference, diabetes  
Model 3 adjusts for Model 2 covariates plus cigarette smoking, alcohol use, physical activity, medication adherence  
Final model for all-cause mortality adjust for Model 3 covariates plus the Physical Component Summary score of the SF-12 
 
Missing data in covariates imputed using chain equations in 10 datasets with sample bootstrapping 
 

























Table S3. Association of concurrent depressive symptoms (CESD≥4) and perceived stress (PSS≥8) with incident total cardiovascular disease, acute coronary heart disease, 
cardiovascular death, and all-cause mortality, separately for REGARDS participants with high or low education. Incidence rates and hazard ratios for the psychosocial risk groups. 
  
  






















  TOTAL CVD (Incident Nonfatal MI, Nonfatal stroke, or Cardiovascular death) 
N of events 1,243 141 50 229 60 29 
Age-adjusted IR./1000 person-years (95% CI) 9.1(8.5-9.7) 10.2(8.7-12.1) 13.0(9.9-17.2)* 19.2(16.7-22.1) 22.3(17.2-28.9) 30.6(21.2-44.0)* 
Crude HR (95% CI) Ref 1.07(0.90-1.28) 1.16(0.87-1.53) Ref 1.10(0.83-1.47) 1.25(0.85-1.84) 
Model 1 HR (95% CI) Ref 1.13(0.95-1.35) 1.39(1.05-1.86) Ref 1.23(0.92-1.64) 1.72(1.16-2.56) 
Model 2 HR (95% CI) Ref 1.09(0.92-1.31) 1.27(0.95-1.69) Ref 1.21(0.90-1.62) 1.77(1.19-2.63) 
Model 3 HR (95% CI) Ref 1.08(0.90-1.28) 1.18(0.88-1.57) Ref 1.22(0.91-1.63) 1.68(1.13-2.52) 
 ACUTE CORONARY HEART DISEASE 
N of events 640 68 23 119 33 12 
Age-adjusted IR./1000 person-years (95% CI) 4.9(4.5-5.4) 5.2(4.1-6.5) 6.0(4.0-9.0) 10.3(8.6-12.5) 12.4(8.8-17.5) 11.7(6.6-20.6) 
Crude HR (95% CI) Ref 1.01(0.78-1.29) 1.02(0.68-1.55) Ref 1.17(0.79-1.72) 0.98(0.53-1.77) 
Model 1 HR (95% CI) Ref 1.11(0.86-1.42) 1.26(0.83-1.92) Ref 1.30(0.88-1.93) 1.22(0.66-2.23) 
Model 2 HR (95% CI) Ref 1.09(0.84-1.40) 1.13(0.74-1.72) Ref 1.26(0.85-1.87) 1.20(0.65-2.20) 
Model 3 HR (95% CI) Ref 1.07(0.83-1.37) 1.05(0.69-1.60) Ref 1.26(0.85-1.87) 1.12(0.61-2.07) 
  CARDIOVASCULAR DEATH 
N of events 454 65 22 118 27 16 
Age-adjusted IR./1000 person-years (95% CI) 2.7(2.4-3.0) 3.8(3.0-4.9)** 4.8(3.2-7.3)** 8.3(6.8-10.3) 8.3(5.6-12.2) 14.2(8.7-23.3)* 
Crude HR (95% CI) Ref 1.38(1.06-1.79) 1.41(0.92-2.17) Ref 0.97(0.64-1.48) 1.34(0.79-2.25) 
Model 1 HR (95% CI) Ref 1.37(1.05-1.78) 1.62(1.05-2.50) Ref 1.09(0.71-1.68) 1.90(1.11-3.25) 
Model 2 HR (95% CI) Ref 1.31(1.01-1.71) 1.55(1.00-2.38) Ref 1.04(0.68-1.59) 1.99(1.16-3.40) 
Model 3 HR (95% CI) Ref 1.27(0.97-1.64) 1.41(0.91-2.18) Ref 1.04(0.68-1.59) 1.99(1.15-3.42) 
  ALL CAUSE MORTALITY 
N of events 1,706 241 91 376 104 50 
Age-adjusted IR./1000 person-years (95% CI) 10.5(9.9-11.1) 14.8(13.0-16.9)*** 20.6(16.8-25.4)*** 28.1(25.1-31.5) 33.7(27.6-41.1) 45.9(34.8-60.6)** 








Crude HR (95% CI) Ref 1.38(1.21-1.58) 1.59(1.29-1.96) Ref 1.19(0.96-1.48) 1.34(0.99-1.80) 
Model 1 HR (95% CI) Ref 1.42(1.24-1.63) 1.87(1.51-2.32) Ref 1.33(1.07-1.67) 1.84(1.36-2.49) 
Model 2 HR (95% CI) Ref 1.26(1.19-1.56) 1.83(1.47-2.27) Ref 1.24(0.99-1.55) 1.97(1.45-2.67) 
Model 3 HR (95% CI) Ref 1.31(1.14-1.50) 1.66(1.33-2.06) Ref 1.24(0.99-1.54) 1.87(1.38-2.55) 
+SF-12 PCS HR (95% CI) Ref 1.18(1.03-1.36) 1.44(1.15-1.79) Ref 1.15(0.91-1.44) 1.61(1.18-2.21) 
Abbreviations: CI=confidence interval. CVD=cardiovascular disease. IR=incidence rate. HR=hazard ratio. MI=myocardial infarction. PCS=Physical Component Summary score of 
the SF-12 
 
*Incidence rate is significantly different, compared to the “No depression/no stress group,” p<.05 
**Incidence rate is significantly different, compared to the “No depression/no stress group,” p≤.01 
***Incidence rate is significantly different, compared to the “No depression/no stress group,” p ≤.001 
 
Model 1 adjusts for age, sex, race, geographic region, number of people in household 
Model 2 adjusts for Model 1 covariates plus systolic blood pressure, self-reported antihypertensive medication use, total cholesterol, HDL-cholesterol, statin use, log-transformed 
albumin to creatinine ratio, log-transformed high-sensitivity C-reactive protein, estimated glomerular filtration rate, waist circumference, diabetes  
Model 3 adjusts for Model 2 covariates plus cigarette smoking, alcohol use, physical activity, medication adherence  
Final model for all-cause mortality adjust for Model 3 covariates plus the Physical Component Summary score of the SF-12 
Missing data in covariates imputed using chain equations in 10 datasets with sample bootstrapping 
 


















W. Davidson, Donald Edmondson, Joshua Richman and Monika M. Safford
Jennifer A. Sumner, Yulia Khodneva, Paul Muntner, Nicole Redmond, Marquita W. Lewis, Karina
Differences in Stroke (REGARDS) Study
Income Participants: Findings From the Reasons for Geographical and Racial− and High−Low
 Effects of Concurrent Depressive Symptoms and Perceived Stress on Cardiovascular Risk in
Online ISSN: 2047-9980 
Dallas, TX 75231
 is published by the American Heart Association, 7272 Greenville Avenue,Journal of the American Heart AssociationThe 
doi: 10.1161/JAHA.116.003930
2016;5:e003930; originally published October 10, 2016;J Am Heart Assoc. 
 http://jaha.ahajournals.org/content/5/10/e003930
World Wide Web at: 
The online version of this article, along with updated information and services, is located on the
 
 for more information. http://jaha.ahajournals.orgAccess publication. Visit the Journal at 
 is an online only OpenJournal of the American Heart AssociationSubscriptions, Permissions, and Reprints: The 
 by guest on N
ovem
ber 3, 2016
http://jaha.ahajournals.org/
D
ow
nloaded from
 
